This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Glenmark Pharmaceuticals S.a.. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2016
Title: Nayan Taterao Waghmare: Innovator in Pharmaceutical Modulation
Introduction
Nayan Taterao Waghmare is a distinguished inventor based in Dist-Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that modulate specific receptors in the human body. With a total of 3 patents to his name, Waghmare's work is paving the way for advancements in medical treatments.
Latest Patents
Waghmare's latest patents focus on thienopyrimidinedione derivatives as TRPA1 modulators. These innovative compounds are designed to treat or prevent diseases, conditions, and disorders that are influenced by the TRPA1 receptor. The patents detail not only the compounds themselves but also the processes for their preparation, the intermediates used in their synthesis, and the pharmaceutical compositions that can be derived from them. This research holds promise for addressing various medical challenges related to TRPA1 modulation.
Career Highlights
Nayan Taterao Waghmare is currently associated with Glenmark Pharmaceuticals S.A., where he continues to push the boundaries of pharmaceutical innovation. His work is characterized by a commitment to developing effective treatments that can improve patient outcomes. Waghmare's expertise in the field has made him a valuable asset to his organization.
Collaborations
Throughout his career, Waghmare has collaborated with notable colleagues, including Sukeerthi Kumar and Abraham Thomas. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking innovations in the pharmaceutical sector.
Conclusion
Nayan Taterao Waghmare is a prominent figure in the realm of pharmaceutical inventions, with a focus on TRPA1 modulation. His contributions are significant in advancing medical science and improving therapeutic options for patients. Waghmare's ongoing work at Glenmark Pharmaceuticals S.A. continues to inspire innovation in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile